Laboratory Corporation of America Holdings (LabCorp(R)) (NYSE:LH), the world’s leading healthcare diagnostics company, and Sequenom, Inc. (NASDAQ: SQNM), a pioneer in non-invasive prenatal testing (NIPT) for reproductive health, today announced that they have entered into a definitive agreement and plan of merger under which LabCorp would acquire all of the outstanding shares of Sequenom in a cash tender offer for $2.40 per share, or an equity value of $302 million, which represents a total enterprise value of approximately $371 million, including net indebtedness.
Morrow Sodali is acting as Information Agent on this merger.
Click here to request documents for this deal.
Related News
The Intelligence Edge: How to Engineer Growth and Lead with Clarity
23 April 2026
Japanese M&A in 2026: Market Momentum Driven by Governance Reform
20 April 2026
Sodali & Co and Luminous Enter Strategic Partnership in Brand & Design
01 April 2026
How Strategic Shareholder Engagement Helped Navigate a Critical Vote at Plug Power
18 February 2026
Media enquiries
To contact our global experts for comments please get in touch below.
Contact us chevron_right